Crestline Management’s Repare Therapeutics RPTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25,101	Closed	-$779K	–	141
2020 Q2	$779K	Buy	+25,101	New	+$779K	0.14%	41